The latest studies have shown that careful targeting of NLRP3 signaling pathways could be beneficial for the treatment of diabetes mellitus and diabetic nephropathy, so the NLRP3 inflammasome should be a new potential target for the treatment of diabetic nephropathy [10–12]. The gene discussed is NLRP3; the disease is diabetes mellitus.